Figure 1

RFX5 overexpression is positively associated with poor prognosis of patients with advanced HCC. (A) The correlation of RFX5 mRNA expression level with RFT in patients with early and intermediate-stage HCC determined by analyzing RNAseq data from the TCGA LIHC dataset. (B) The correlation of RFX5 mRNA expression level with RFT in patients with advanced stage HCC determined by analyzing RNAseq from the TCGA LIHC dataset. (C) The correlation of RFX5 protein expression with OST in patients with advanced stage HCC determined by IHC analysis.